Literature DB >> 3501703

In vitro susceptibility of Haemophilus influenzae to cefixime.

M Powell1, J D Williams.   

Abstract

The in vitro activity of cefixime against 2,458 clinical isolates of Haemophilus influenzae was determined. All the strains were inhibited by less than or equal to 2 micrograms of cefixime per ml, and the modal MIC was 0.03 micrograms/ml. Activity was unaffected by the presence of beta-lactamase produced by 157 isolates. Nineteen of the twenty-four isolates for which cefixime MICs were greater than or equal to 0.5 micrograms/ml were beta-lactamase negative but showed reduced susceptibility to ampicillin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501703      PMCID: PMC175049          DOI: 10.1128/AAC.31.11.1841

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. Report of a study group on bacterial resistance.

Authors:  A J Howard; C J Hince; J D Williams
Journal:  Br Med J       Date:  1978-06-24

2.  Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986.

Authors:  M Powell; C Koutsia-Carouzou; D Voutsinas; A Seymour; J D Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

3.  Letter: Penicillinase production by Haemophilus influenzae.

Authors:  J D Williams; S Kattan; P Cavanagh
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

4.  A rapid method for the differentiation of Haemophilus strains. The porphyrin test;.

Authors:  M Kilian
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-12

5.  Increase in antibiotic resistance in Haemophilus influenzae in the United Kingdom since 1977: report of study group.

Authors:  J Philpott-Howard; J D Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29

6.  Mechanism of renal excretion of FK027 in dogs and rabbits.

Authors:  H Sakamoto; T Hirose; S Nakamoto; Y Mine
Journal:  J Antibiot (Tokyo)       Date:  1985-08       Impact factor: 2.649

7.  The pharmacokinetic and bactericidal characteristics of oral cefixime.

Authors:  D C Brittain; B E Scully; T Hirose; H C Neu
Journal:  Clin Pharmacol Ther       Date:  1985-11       Impact factor: 6.875

8.  Pharmacokinetics of FK027 in rats and dogs.

Authors:  H Sakamoto; T Hirose; Y Mine
Journal:  J Antibiot (Tokyo)       Date:  1985-04       Impact factor: 2.649

9.  Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance.

Authors:  B W Catlin
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

10.  Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.

Authors:  H C Neu; N X Chin; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

View more
  6 in total

1.  In vitro activity of new antibiotics against Haemophilus influenzae.

Authors:  K Machka; H Balg; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

2.  In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.

Authors:  P M Mendelman; L L Henritzy; D O Chaffin; K Lent; A L Smith; T L Stull; E A Wiley
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

3.  Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.

Authors:  J E Mortensen; S L Himes
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

Review 4.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

5.  Cefixime penetration in human renal parenchyma.

Authors:  A Leroy; B Oser; P Grise; G Humbert
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 6.  Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.

Authors:  R N Brogden; D M Campoli-Richards
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.